Description
+ Include: 3 videos + 13 pdfs, size: 7.05 GB
+ Target Audience: rheumatologist
+ Sample video: contact me for sample video
+ Information:
Friday, April 28, 2023, 11:30 AM – Saturday, April 29, 2023, 1:30 PM, Maurice R. Greenberg Conference Center, New Haven, CT
DATE | TIME |
April 28, 2023 | 12:00 PM—4:40 PM EST |
April 29, 2023 | 7:00 AM—1:30 PM EST |
Over the past 20 years, rheumatology has witnessed tremendous therapeutic advances. Progress in treatment with traditional small molecules and the rise of biologic therapy offers improved outcomes for rheumatic disease patients. With advances in efficacy comes increasing therapeutic complexity and the need to avoid harm.
In this two-day Yale Symposium, we will bring together a faculty of internationally recognized experts to discuss risk mitigation for rheumatic disease patients. We will also consider the needs of special populations such as underserved, pregnant, and peri-operative patients and the role of vaccination.
PLANNERS
COURSE DIRECTOR |
Robert Schoen MD, MBA Clinical Professor of Rheumatology Yale School of Medicine |
CO-DIRECTORS |
Richard Bucala MD, PhD Chief, Rheumatology, Allergy & Immunology Waldemar Von Zedtwitz Professor of Medicine, Pathology, and Epidemiology & Public Health Yale University Rheumatologist-in-Chief Yale New Haven Health |
Vaidehi Chowdhary, MBBS, MD, DM Associate Professor Clinical Chief, Rheumatology, Allergy, & Immunology Yale School of Medicine |
- Better recognize and mitigate risk in rheumatic disease patients.
- Discuss the role of vaccination in rheumatic disease patients.
- Review the needs of special rheumatic disease populations, including underserved, pregnant, and peri-operative patients
+ Topics:
*Note: these are continuous video recordings during the conference, they include individual lectures mentioned in the Detail section below
April 28.mp4
April 29 Part 1.mp4
April 29 Part 2.mp4
Assessment of Infection Risk in Rheumatic Disease Patients Treated with Biologic Therapy.pdf
Benefit and Risk in the Treatment of Gout.pdf
Checkpoint Inhibitors- Musculoskeletal Manifestations and Treatment.pdf
Genetic and Socioeconomic Risk Disparities in Rheumatic Disease Treatment..pdf
Hydroxychloroquine Toxicity.pdf
Management of Rheumatic Disease in Pregnancy.pdf
Methotrexate Risk in Rheumatology.pdf
Mitigating Glucocorticoid Toxicity.pdf
Perioperative Management of Immunosuppression in Patients with Rheumatoid Arthritis.pdf
Rheumatology Symposium 2023_Agenda and Program Overview__v4_NVP_FINAL.pdf
Safety of Jak Inhibitors.pdf
The Clinical Manifestations, Prevention, and Treatment of COVID Infection in Rheumatology Patients.pdf
Vaccines and Biologics.pdf
*Detail:
Reviews
There are no reviews yet.